146 related articles for article (PubMed ID: 32821751)
1. Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in
Bahrololoumi Shapourabadi M; Roohvand F; Arashkia A; Mohajel N; Abdoli S; Shahosseini Z; Momburg F; Jarahian M; Abolhassani M; Azadmanesh K
Rep Biochem Mol Biol; 2020 Apr; 9(1):50-57. PubMed ID: 32821751
[TBL] [Abstract][Full Text] [Related]
2. Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy.
Bahrololoumi Shapourabadi M; Momburg F; Roohvand F; Jarahian M; Mohajel N; Arashkia A; Hajari Taheri F; Abbasalipour M; Azadmanesh K
Int Immunopharmacol; 2021 Jul; 96():107762. PubMed ID: 34162140
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.
McCall AM; Adams GP; Amoroso AR; Nielsen UB; Zhang L; Horak E; Simmons H; Schier R; Marks JD; Weiner LM
Mol Immunol; 1999 May; 36(7):433-45. PubMed ID: 10449096
[TBL] [Abstract][Full Text] [Related]
4. A trivalent anti-erbB2/anti-CD16 bispecific antibody retargeting NK cells against human breast cancer cells.
Xie Z; Shi M; Feng J; Yu M; Sun Y; Shen B; Guo N
Biochem Biophys Res Commun; 2003 Nov; 311(2):307-12. PubMed ID: 14592414
[TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of anti-GD2/anti-CD16 single-chain bispecific antibody].
Ni J; Ji J; Bai X; Lu A; Huang R; Wei Y; Wu W
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):659-63. PubMed ID: 17713283
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of hemagglutinin-neuraminidase protein from Newcastle disease virus in Bacillus subtilis WB800.
Shafaati M; Ghorbani M; Mahmoodi M; Ebadi M; Jalalirad R
J Genet Eng Biotechnol; 2022 May; 20(1):77. PubMed ID: 35608724
[TBL] [Abstract][Full Text] [Related]
7. [Construction and expression of anti-CD3/anti-prostate-cancer bispecific single-chain antibody].
Wang D; Wu GJ; Wang H; Yang SL; Wu WZ; Xu TZ; Tan JM
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1292-5. PubMed ID: 12930679
[TBL] [Abstract][Full Text] [Related]
8. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.
Jarahian M; Watzl C; Fournier P; Arnold A; Djandji D; Zahedi S; Cerwenka A; Paschen A; Schirrmacher V; Momburg F
J Virol; 2009 Aug; 83(16):8108-21. PubMed ID: 19515783
[TBL] [Abstract][Full Text] [Related]
9. [Study on p53 tetramerization domain in improving functional affinity and biological activity of antibody].
Wang D; Wu GJ; Tan JM; Wang H
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):479-82. PubMed ID: 15854555
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitumor effect of a trivalent bispecific antibody targeting ErbB2 and CD16.
Lu H; Shi M; Wang M; Xie Z; Hu M; Yu M; Shen B; Ma Y; Guo N
Cancer Biol Ther; 2008 Nov; 7(11):1744-50. PubMed ID: 18787406
[TBL] [Abstract][Full Text] [Related]
11. Effective introduction of T cell costimulatory molecules into virus modified tumor cell vaccines by modification with bispecific antibodies.
Haas C; Schirrmacher V
Int J Oncol; 1997 Nov; 11(5):951-7. PubMed ID: 21528289
[TBL] [Abstract][Full Text] [Related]
12. Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity.
McCall AM; Shahied L; Amoroso AR; Horak EM; Simmons HH; Nielson U; Adams GP; Schier R; Marks JD; Weiner LM
J Immunol; 2001 May; 166(10):6112-7. PubMed ID: 11342630
[TBL] [Abstract][Full Text] [Related]
13. E. coli expression and immunological assessment of expressed recombinant Newcastle disease virus hemagglutinin-neuraminidase protein in chickens.
Shahid N; Rao AQ; Ahad A; Gul A; Latif A; Azam S; Shahid M; Akhtar S; Shahid AA; Husnain T
Acta Virol; 2020; 64(3):331-337. PubMed ID: 32985210
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells.
Silla LM; Chen J; Zhong RK; Whiteside TL; Ball ED
Br J Haematol; 1995 Apr; 89(4):712-8. PubMed ID: 7772507
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC.
van Faassen H; Jo DH; Ryan S; Lowden MJ; Raphael S; MacKenzie CR; Lee SH; Hussack G; Henry KA
Mol Pharm; 2021 Jun; 18(6):2375-2384. PubMed ID: 33999642
[TBL] [Abstract][Full Text] [Related]
16. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
Shen J; Vil MD; Jimenez X; Iacolina M; Zhang H; Zhu Z
J Biol Chem; 2006 Apr; 281(16):10706-14. PubMed ID: 16481314
[TBL] [Abstract][Full Text] [Related]
17. Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity.
Li J; Zhou C; Dong B; Zhong H; Chen S; Li Q; Wang Z
Cancer Biol Ther; 2016 Dec; 17(12):1231-1239. PubMed ID: 27645568
[TBL] [Abstract][Full Text] [Related]
18. [Targeted inhibition of rabies virus replication in vitro by single chain antibody domain mediated vector expression shRNA delivery].
Yang R; Cui Y; Yang S; Wang C; Shan H; Wang H; Xia X
Wei Sheng Wu Xue Bao; 2010 Feb; 50(2):256-62. PubMed ID: 20387470
[TBL] [Abstract][Full Text] [Related]
19. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25.
Fournier P; Aigner M; Schirrmacher V
Int J Oncol; 2010 Dec; 37(6):1439-52. PubMed ID: 21042712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
